Can You Take Phenytoin and Fluconazole Together? What You Need to Know About This Drug Interaction
Fluconazole may increase phenytoin blood levels. Learn the documented interaction, mechanism, and why monitoring is recommended.
No, theophylline and cimetidine should not be used together without careful medical supervision and monitoring. Cimetidine is documented to reduce how your body breaks down theophylline, causing theophylline blood levels to rise to potentially harmful levels. This is classified as a major interaction that has been associated with adverse clinical effects. If you are taking both medications, your doctor and pharmacist need to know and should monitor your theophylline levels closely.
According to drug-interaction data from the National Library of Medicine, cimetidine causes a major interaction with theophylline. The source record describes the interaction as follows: "Cimetidine reduces hepatic metabolism of theophylline, increasing blood levels. Adverse clinical effects reported. Alteration less pronounced with 800 mg bedtime dosing. Appropriate monitoring recommended."
The documented mechanism is inhibition of hepatic microsomal enzyme metabolism—meaning cimetidine interferes with the liver's ability to process and eliminate theophylline from your body. Because the drug is not broken down as quickly, it accumulates, and blood concentrations rise.
This interaction is considered major because theophylline is a narrow-therapeutic-index drug, meaning the difference between a safe dose and a toxic dose is relatively small. When blood levels climb unexpectedly, serious adverse effects can occur.
To understand why this interaction happens, it helps to know what these two medications do and how your body processes them.
Theophylline is a bronchodilator—a medication that relaxes the muscles in the airways to improve breathing. It is used to treat asthma and chronic obstructive pulmonary disease (COPD). Your liver metabolizes theophylline; specifically, liver enzymes in a family called the cytochrome P450 system (particularly the CYP1A2 enzyme) break down the drug so it can be eliminated from your body.
Cimetidine is an H2-receptor antagonist—a medication that reduces stomach acid production. It is used to treat acid reflux, heartburn, and peptic ulcers. While cimetidine is primarily used for its acid-reducing effect, it also has the unintended consequence of inhibiting several liver enzymes, including some of the cytochrome P450 enzymes that metabolize theophylline.
The documented mechanism—inhibition of hepatic microsomal enzyme metabolism—describes exactly this process. When cimetidine blocks the enzymes responsible for breaking down theophylline, the drug lingers in your bloodstream longer and at higher concentrations than intended. This elevation in blood level is what leads to adverse clinical effects.
The source record notes that the alteration is "less pronounced with 800 mg bedtime dosing." This refers to a specific dosing regimen of cimetidine (800 mg taken at bedtime) that produces a smaller reduction in theophylline metabolism than higher total daily doses or different timing schedules. However, even with this dosing, the interaction is still present and requires monitoring.
Anyone taking both theophylline and cimetidine together should be aware of this interaction and ensure their prescribing physician and pharmacist know about both medications. Because theophylline has a narrow therapeutic index, the risk of toxicity increases when blood levels rise due to impaired metabolism.
Individuals on long-term theophylline therapy who begin cimetidine treatment (or vice versa) are at particular risk because the interaction may cause previously stable theophylline levels to climb. Similarly, changes in cimetidine dose or discontinuation can alter the degree of interaction, affecting theophylline levels in either direction.
Imagine a patient with mild COPD who has been stable on a theophylline dose for several months, with blood levels in the therapeutic range. The patient then develops acid reflux and is prescribed cimetidine by a different clinician who is unaware of the theophylline therapy. Within days to weeks, cimetidine begins to inhibit the liver enzymes that normally clear theophylline. The patient's theophylline blood level rises above the intended therapeutic range. The patient may start to experience theophylline toxicity symptoms such as nausea, tremor, headache, or irregular heartbeat—symptoms that would not have appeared if the medications had been coordinated. This scenario underscores why it is critical to inform all your healthcare providers about every medication you take.
Conversely, suppose a patient has been taking theophylline and cimetidine together under close monitoring, with the cimetidine dose adjusted or theophylline dose reduced to account for the interaction. If the patient stops cimetidine (for instance, because the ulcer has healed), the hepatic enzyme inhibition gradually reverses. The liver enzymes resume their normal rate of theophylline metabolism, and theophylline blood levels fall. If the theophylline dose was not adjusted upward when cimetidine was discontinued, the patient might experience a loss of therapeutic benefit—inadequate bronchodilation and worsening respiratory symptoms. This underscores that managing this interaction requires coordinated, ongoing communication between patient, prescriber, and pharmacist.
If you are currently taking both theophylline and cimetidine, or if you need to start one while already taking the other, have these conversations with your healthcare team:
This article is based on drug-interaction data from the National Library of Medicine (NLM). For more information about these medications and their interactions, consult these authoritative resources:
Always verify current prescribing information with your pharmacist or by consulting DailyMed, as drug information and recommendations can change.
If you are taking theophylline, cimetidine, or both, check your full medication list at checkdruginteractions.com to see all documented interactions. Enter your medications to get a comprehensive picture of potential drug interactions. Then, confirm any clinical decisions about your medications—including whether to continue, change, or monitor a combination—with your pharmacist or physician. Do not start, stop, or adjust any medication on your own based on this article. Your healthcare team has the full context of your medical history and can make personalized recommendations.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Fluconazole may increase phenytoin blood levels. Learn the documented interaction, mechanism, and why monitoring is recommended.
Amiodarone is a major-severity drug interaction with warfarin. Learn how it affects your blood thinner and what monitoring means.
A major drug interaction between methotrexate and aspirin can increase methotrexate levels. Learn what this means and how to discuss it w...